Showing results (61-70 of 136) with videos related to
Sort By:
Pageof 14
The Journal of Experimental Medicine|July 1, 1995
Interleukin 6 is essential for in vivo development of B lineage neoplasmsD M Hilbert, M Kopf, B A Mock, et al.Molecular Pharmacology|March 1, 1996
Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1)L A Dowd, A J Coyle, J D Rothstein, et al.The Journal of Allergy and Clinical Immunology|December 1, 1989
Modification of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by the selective platelet-activating factor antagonist, BN 52021A J Coyle, C P Page, L Atkinson, et al.European Journal of Pharmacology|March 22, 1988
The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulationA J Coyle, S C Urwin, C P Page, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient miceW J Dai, W Bartens, G Köhler, et al.Journal of Voice : Official Journal of the Voice Foundation|November 23, 2017
The Perception of Breathiness in the Voices of Pediatric SpeakersLisa M Kopf, Mark D Skowronski, Supraja Anand, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infectionA K Bromander, L Ekman, M Kopf, et al.Immunological Reviews|January 4, 2001
Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lungJ C Gutierrez-Ramos, C Lloyd, M L Kapsenberg, et al.Immunity|July 1, 1996
Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathwayD M Hilbert, T S Migone, M Kopf, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activationJ A Gonzalo, T Delaney, J Corcoran, et al.Pageof 14